Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Hideki Ushiku being referenced
Neoadjuvant chemotherapy plus surgery for high-risk advanced gastric cancer: Long-term results of KDOG1001 trial.
2020
Prognostic relevance of FGFR2 expression in stage�II/III gastric cancer with curative resection and S‑1 chemotherapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hideki Ushiku | 187 | 147 | 222 | 156 | 38 | 467 | |
| Eugenio Fiorentino | 151 | 173 | 205 | 148 | 41 | 557 | |
| Takeshi Toyozumi | 127 | 120 | 239 | 129 | 57 | 469 | |
| Qirong Geng | 155 | 118 | 161 | 108 | 25 | 446 | |
| Qingsi He | 94 | 142 | 237 | 93 | 34 | 490 | |
| Yanying Shen | 149 | 97 | 251 | 140 | 40 | 506 | |
| Matthew Chau Hsien Ng | 161 | 126 | 157 | 196 | 43 | 442 | |
| Tao Sun | 98 | 183 | 200 | 216 | 36 | 525 | |
| Laura L. Meijer | 105 | 125 | 184 | 259 | 32 | 456 | |
| Manabu Yamamoto | 249 | 116 | 159 | 231 | 26 | 546 | |
| Jiadi Xing | 203 | 154 | 150 | 175 | 47 | 479 |
All Works
Login with ORCID to disown or claim papers
Loading papers...